Nurix Therapeutics, Inc. Common stock (NRIX) is a publicly traded Healthcare sector company. As of October 5, 2026, NRIX trades at $22.86 with a market cap of $2.39B and a P/E ratio of -6.65. NRIX moved -0.58% today. Year to date, NRIX is +21.19%; over the trailing twelve months it is +153.19%. Its 52-week range spans $8.18 to $28.23. Analyst consensus is strong buy with an average price target of $34.50. Rallies surfaces NRIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
10 analysts cover NRIX: 0 strong buy, 9 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $34.50.
| Metric | Value |
|---|---|
| Price | $22.86 |
| Market Cap | $2.39B |
| P/E Ratio | -6.65 |
| EPS | $-3.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $28.23 |
| 52-Week Low | $8.18 |
| Volume | 28.64K |
| Avg Volume | 0 |
| Revenue (TTM) | $36.77M |
| Net Income | $-341.35M |
| Gross Margin | 0.00% |
10 analysts cover NRIX: 0 strong buy, 9 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.50.